Cost-effectiveness of Combined Outreach for the Pneumococcal and Influenza Vaccines | Zendy

Marcia R. Weaver | Zendy; JAMES KRIEGER | Zendy; Joseph Castorina | Zendy; Mary Walls | Zendy; Sandy Ciske | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cost-effectiveness of Combined Outreach for the Pneumococcal and Influenza Vaccines

Author(s) -

Marcia R. Weaver,

JAMES KRIEGER,

Joseph Castorina,

Mary Walls,

Sandy Ciske

Publication year - 2001

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinte.161.1.111

Subject(s) - medicine , outreach , vaccination , influenza vaccine , cost effectiveness , cost effectiveness analysis , confidence interval , quality adjusted life year , cost–benefit analysis , randomized controlled trial , incremental cost effectiveness ratio , pneumococcal vaccine , economic evaluation , family medicine , pediatrics , environmental health , immunology , streptococcus pneumoniae , biology , genetics , pathology , political science , bacteria , law , ecology , risk analysis (engineering)

We conducted a cost-effectiveness analysis as part of a randomized, controlled trial of a community-based outreach initiative to promote the pneumococcal and influenza vaccines for people aged 65 years or older.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research